Bank of Montreal
FATE icon

Bank of Montreal’s Fate Therapeutics FATE Stock Holding History

Bank of Montreal’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,400
Closed -$664K – 4066
2021
Q1 		$664K Sell
8,400
-600
-7% -$57.5K ﹤0.01% 2473
2020
Q4 		$1.01M Buy
+9,000
New +$559K ﹤0.01% 2239

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of Montreal's FATE Position: Q2 2021 in Review

Bank of Montreal sold out of Fate Therapeutics (FATE) in Q2 2021, closing a stake of 3,405 shares — an estimated $269K sold.

Bank of Montreal first reported a position in FATE in Q1 2015 and held it in 22 quarters. The position peaked at $1.29M in Q4 2020. 272 funds tracked by Wall St. Rank hold FATE as of Q2 2021.

  • Bank of Montreal reported no remaining Fate Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 3,405 Fate Therapeutics shares in Q2 2021, an estimated $269K.
  • Bank of Montreal first reported a position in Fate Therapeutics in Q1 2015 and held it in 22 quarters.
  • Bank of Montreal's Fate Therapeutics position peaked at $1.29M in Q4 2020.
  • 272 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.